Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Early Pipeline Case Study

- PMLiVE

Oliver Group buys digital agency Dare

The firm's clients include Public Health England and Cancer Research UK

Eli Lilly HQ

Lilly wins breakthrough designation for breast cancer drug

CDK 4 and 6 inhibitor Abemaciclib's development to be expedited by FDA

- PMLiVE

FDA fast-tracks Merck/Pfizer’s rare skin cancer drug avelumab

Comes a month after drug was given orphan status

Osmotica Pharmaceuticals appoints new vice president

Samer Kaba joins the firm

- PMLiVE

Indian court blocks generic of Merck’s Januvia

Follows a series of setbacks in Indian courts for multinational pharma companies

- PMLiVE

Sanofi posts positive data for MS drug Aubagio

Phase III study shows drug slows brain volume loss

Novo launches online news channel for haemophilia patients

New medical information website aims to be a 'simple, centralised repository'

- PMLiVE

FDA approves Alkermes’ long-acting Abilify

Aristada given the nod as injectable antipsychotic

- PMLiVE

Guido Rasi set for return as EMA executive director

Regulator's board nominates him to resume hisleadership role

- PMLiVE

Express Scripts ‘will pay $750m on PCSK9 inhibitors next year’

Amgen's Repatha and Sanofi's Praluent included

- PMLiVE

Axovant takes Alzheimer’s drug into phase III

Aims to bring first treatment in a decade to market

- PMLiVE

Mission Therapeutics appoints new chief financial officer

David Luther joins with 25 years healthcare and pharmaceutical experience

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links